Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
PLoS One. 2012;7(12):e52081. doi: 10.1371/journal.pone.0052081. Epub 2012 Dec 17.
The role of inflammation in atherosclerosis is widely appreciated. High mobility group box 1 (HMGB1), an injury-associated molecular pattern molecule acting as a mediator of inflammation, has recently been implicated in the development of atherosclerosis. In this study, we sought to investigate the association of plasma HMGB1 with coronary plaque composition in patients with suspected or known coronary artery disease (CAD).
HMGB1, high sensitive troponin T (hsTnT) and high sensitive C-reactive protein (hsCRP) were determined in 152 consecutive patients with suspected or known stable CAD who underwent clinically indicated 256-slice coronary computed tomography angiography (CCTA). Using CCTA, we assessed 1) coronary calcification, 2) non-calcified plaque burden and 3) the presence of vascular remodeling in areas of non-calcified plaques.
Using univariate analysis, hsCRP, hsTnT and HMGB1 as well as age, and atherogenic risk factors were associated with non-calcified plaque burden (r = 0.21, p = 0.009; r = 0.48, p<0.001 and r = 0.34, p<0.001, respectively). By multivariate analysis, hsTnT and HMGB1 remained independent predictors of the non-calcified plaque burden (r = 0.48, p<0.01 and r = 0.34, p<0.001, respectively), whereas a non-significant trend was noticed for hs-CRP (r = 0.21, p = 0.07). By combining hsTnT and HMGB1, a high positive predictive value for the presence of non-calcified and remodeled plaque (96% and 77%, respectively) was noted in patients within the upper tertiles for both biomarkers, which surpassed the positive predictive value of each marker separately.
In addition to hs-TnT, a well-established cardiovascular risk marker, HMGB1 is independently associated with non-calcified plaque burden in patients with stable CAD, while the predictive value of hs-CRP is lower. Complementary value was observed for hs-TnT and HMGB1 for the prediction of complex coronary plaque.
炎症在动脉粥样硬化中的作用已得到广泛认识。高迁移率族蛋白 B1(HMGB1)作为炎症的介质,是一种与损伤相关的分子模式分子,最近被认为与动脉粥样硬化的发展有关。在这项研究中,我们试图探讨在疑似或已知冠心病(CAD)患者中,血浆 HMGB1 与冠状动脉斑块成分之间的关系。
在接受临床推荐的 256 层冠状动脉计算机断层血管造影术(CCTA)的 152 例疑似或已知稳定 CAD 连续患者中,测定 HMGB1、高敏肌钙蛋白 T(hsTnT)和高敏 C 反应蛋白(hsCRP)。使用 CCTA,我们评估了 1)冠状动脉钙化,2)非钙化斑块负担和 3)非钙化斑块区域的血管重构。
采用单因素分析,hsCRP、hsTnT 和 HMGB1 以及年龄和动脉粥样硬化危险因素与非钙化斑块负担相关(r=0.21,p=0.009;r=0.48,p<0.001 和 r=0.34,p<0.001)。多因素分析显示,hsTnT 和 HMGB1 仍然是非钙化斑块负担的独立预测因子(r=0.48,p<0.01 和 r=0.34,p<0.001),而 hs-CRP 呈显著趋势(r=0.21,p=0.07)。结合 hsTnT 和 HMGB1,在两个生物标志物的上三分位数中,非钙化和重塑斑块的阳性预测值均较高(分别为 96%和 77%),超过了每个标志物单独的阳性预测值。
除了 hs-TnT 这一已确立的心血管风险标志物外,HMGB1 还与稳定 CAD 患者的非钙化斑块负担独立相关,而 hs-CRP 的预测价值较低。hs-TnT 和 HMGB1 对预测复杂冠状动脉斑块具有互补价值。